|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
251,510,000 |
Market
Cap: |
104.12(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$365.83 - $556.89 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 10 |
Guru Rank Value : 25.7 |
Guru Occurances : 5 |
|
|
|
|
|
|
|
Company Profile Elevance Health is an insurance holding company. Co. is a health benefits company, serving medical members through its affiliated health plans. Co. has four segments: Commercial and Specialty Business, which provides fully-insured health products, managed care services; Government Business, which includes Medicare and Medicaid businesses, its subsidiary, National Government Services, and services provided to the federal government in connection with its Federal Health Products and Services business; IngenioRx, which includes its pharmacy benefit management business; and Other, which includes Diversified Business Group, which is its integrated health services business.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
8,535 |
8,535 |
51,010 |
103,437 |
Total Sell Value |
$3,521,612 |
$3,521,612 |
$24,314,986 |
$51,090,652 |
Total People Sold |
3 |
3 |
6 |
9 |
Total Sell Transactions |
3 |
3 |
7 |
17 |
End Date |
2025-02-06 |
2024-11-05 |
2024-05-07 |
2023-05-08 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kaye Mark |
EVP & CFO |
|
2025-04-24 |
4 |
S |
$424.82 |
$1,949,074 |
D/D |
(4,588) |
18,977 |
|
4% |
|
Penczek Ronald W |
CAO & Controller |
|
2025-03-10 |
4 |
S |
$415.13 |
$183,903 |
D/D |
(443) |
1,847 |
|
-0% |
|
Kendrick Charles Morgan Jr |
EVP & President, Commercial |
|
2025-03-05 |
4 |
S |
$396.30 |
$1,388,635 |
D/D |
(3,504) |
10,116 |
|
-3% |
|
Norwood Felicia F |
EVP & President,Gov Health Ben |
|
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,248 |
31,939 |
|
- |
|
Norwood Felicia F |
EVP & President,Gov Health Ben |
|
2025-03-03 |
4 |
D |
$395.50 |
$1,033,442 |
D/D |
(2,613) |
24,691 |
|
- |
|
Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
|
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
7,248 |
26,004 |
|
- |
|
Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
|
2025-03-03 |
4 |
D |
$395.50 |
$902,136 |
D/D |
(2,281) |
18,756 |
|
- |
|
Kendrick Charles Morgan Jr |
EVP & President, Commercial |
|
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
6,531 |
13,620 |
|
- |
|
Kendrick Charles Morgan Jr |
EVP & President, Commercial |
|
2025-03-03 |
4 |
D |
$395.50 |
$878,406 |
D/D |
(2,221) |
7,089 |
|
- |
|
Lavu Ratnakar |
EVP, Chief Digital & Info Off |
|
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
2,339 |
4,783 |
|
- |
|
Lavu Ratnakar |
EVP, Chief Digital & Info Off |
|
2025-03-03 |
4 |
D |
$395.50 |
$123,396 |
D/D |
(312) |
2,444 |
|
- |
|
Penczek Ronald W |
CAO & Controller |
|
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
706 |
2,290 |
|
- |
|
Penczek Ronald W |
CAO & Controller |
|
2025-03-03 |
4 |
D |
$395.50 |
$78,309 |
D/D |
(198) |
1,584 |
|
- |
|
Kaye Mark |
EVP & CFO |
|
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
3,604 |
23,565 |
|
- |
|
Kaye Mark |
EVP & CFO |
|
2025-03-03 |
4 |
D |
$395.50 |
$106,785 |
D/D |
(270) |
19,961 |
|
- |
|
Boudreaux Gail |
President and CEO |
|
2025-03-03 |
4 |
A |
$0.00 |
$0 |
D/D |
26,207 |
142,520 |
|
- |
|
Boudreaux Gail |
President and CEO |
|
2025-03-03 |
4 |
D |
$395.50 |
$4,111,618 |
D/D |
(10,396) |
116,313 |
|
- |
|
Todt Blair Williams |
EVP, CLO & CAO |
|
2025-01-03 |
4 |
D |
$371.56 |
$147,881 |
D/D |
(398) |
15,631 |
|
- |
|
Kendrick Charles Morgan Jr |
EVP & President, Commercial |
|
2024-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,710 |
9,287 |
|
- |
|
Kendrick Charles Morgan Jr |
EVP & President, Commercial |
|
2024-11-01 |
4 |
D |
$414.01 |
$350,252 |
D/D |
(846) |
7,577 |
|
- |
|
Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
|
2024-11-01 |
4 |
A |
$0.00 |
$0 |
D/D |
3,799 |
21,037 |
|
- |
|
Haytaian Peter D |
EVP & Pres Carelon & CarelonRx |
|
2024-11-01 |
4 |
D |
$414.01 |
$682,702 |
D/D |
(1,649) |
17,238 |
|
- |
|
Kendrick Charles Morgan Jr |
EVP & President, Commercial |
|
2024-10-18 |
4 |
S |
$432.14 |
$3,205,182 |
D/D |
(7,417) |
8,423 |
|
8% |
|
Kaye Mark |
EVP & CFO |
|
2024-10-02 |
4 |
D |
$505.16 |
$1,423,541 |
D/D |
(2,818) |
20,213 |
|
- |
|
Peru Ramiro G |
Director |
|
2024-08-05 |
4 |
AS |
$531.52 |
$400,235 |
D/D |
(753) |
8,744 |
|
-28% |
|
570 Records found
|
|
Page 1 of 23 |
|
|